More News
18 December 2013
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO)17 December 2013
Stelis Biopharma and Pieris Forge Alliance for Novel Anticalin® Therapeutics in Ophthalmology17 December 2013
Almirall reaches an agreement to acquire Aqua Pharmaceuticals, a US- based specialty dermatology company16 December 2013
Endo to Acquire Specialty Pharmaceutical Company NuPathe13 December 2013
BIND Therapeutics and Amgen Amend Collaboration Agreement for Kinase Inhibitor Nanomedicine12 December 2013
Roche and Prothena Enter Into Worldwide Collaboration to Co-Develop and Co-Promote Antibodies for Treatment of Parkinson’s Disease12 December 2013
EMERGENT BIOSOLUTIONS TO ACQUIRE CANGENE CORPORATION10 December 2013
Covagen Secures CHF 42 Million in Series B Financing7 December 2013
Kolltan Pharmaceuticals Licenses Novel anti-KIT Antibodies and Related Intellectual Property from the University of Toronto4 December 2013
Leading Cancer Research Centers Team Up To Launch Biotech Startup Focused On Cancer Immunotherapy4 December 2013
Genmab Announces Expansion of DuoBody Platform Collaboration with Janssen Biotech, Inc4 December 2013
The Medicines Company Acquires Rempex PharmaceuticalsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports